Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,851 public trials 1,786 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

NCT01482156

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +20 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • Washington University School of Medicine Washington University (16) St Louis, Missouri, United States
  • Medical University of South Carolina SC Charleston, South Carolina, United States
  • Novartis Investigative Site Wilrijk, Belgium
View Trial Details
Completed

A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer

NCT01598077

Conditions
Breast Diseases, Breast Neoplasms, Carcinoma, +22 more
Locations
  • University of Chicago Medical Center University of Chicago (16) Chicago, Illinois, United States
  • Massachusetts General Hospital SC-5 Boston, Massachusetts, United States
  • University of Texas/MD Anderson Cancer Center UT MD Houston, Texas, United States
  • University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States
View Trial Details
Completed

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

NCT01576666

Conditions
Advanced Pancreatic Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +35 more
Locations
  • Cedars Sinai Medical Center SC Los Angeles, California, United States
  • University of California San Francisco UCSF (SC) San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • Dana Farber Cancer Institute Dana SC Boston, Massachusetts, United States
View all 23 locations
View Trial Details
Completed

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

NCT02152943

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.

NCT02154776

Conditions
Advanced or Metastatic Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of California at Los Angeles UCLA SC Los Angeles, California, United States
  • Horizon Oncology Center SC Lafayette, Indiana, United States
  • Medical University of South Carolina SC Charleston, South Carolina, United States
  • South Texas Accelerated Research Therapeutics SC San Antonio, Texas, United States
View Trial Details
Completed

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

NCT00788931

Conditions
Breast Diseases, Breast Neoplasms, HER-2 Positive Breast Cancer, +5 more
Locations
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Woodville, South Australia, Australia
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Liège, Belgium
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

NCT02308020

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +28 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California - San Diego La Jolla, California, United States
  • Univ of California San Francisco San Francisco, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View all 44 locations
View Trial Details
Completed

Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer

NCT00958971

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Comprehensive Blood and Cancer Center Dept CBCC (3) Bakersfield, California, United States
  • Tower Cancer Research Beverly Hills, California, United States
  • UCLA/ University of California Los Angeles Div. of Hematology/Oncology Los Angeles, California, United States
  • Cancer Care Associates Medical Group Dept. of CCA Redondo Beach, California, United States
View all 38 locations
View Trial Details
Completed

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

NCT00526045

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • UCLA/ University of California Los Angeles UCLA Los Angeles, California, United States
  • Georgia Health Sciences University Med College of GA Augusta, Georgia, United States
  • Dana Farber Cancer Institute StudyCoordinator:CAUY922A2101 Boston, Massachusetts, United States
  • Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. St Louis, Missouri, United States
View Trial Details

Related conditions